GB9822440D0 - Medicaments - Google Patents

Medicaments

Info

Publication number
GB9822440D0
GB9822440D0 GBGB9822440.5A GB9822440A GB9822440D0 GB 9822440 D0 GB9822440 D0 GB 9822440D0 GB 9822440 A GB9822440 A GB 9822440A GB 9822440 D0 GB9822440 D0 GB 9822440D0
Authority
GB
United Kingdom
Prior art keywords
medicaments
derivatives
mammals
man
useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9822440.5A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GBGB9822440.5A priority Critical patent/GB9822440D0/en
Publication of GB9822440D0 publication Critical patent/GB9822440D0/en
Priority to AT99950730T priority patent/ATE312831T1/de
Priority to ES99950730T priority patent/ES2255306T3/es
Priority to PCT/EP1999/007766 priority patent/WO2000021952A1/en
Priority to AU63395/99A priority patent/AU6339599A/en
Priority to JP2000575858A priority patent/JP2002527434A/ja
Priority to EP99950730A priority patent/EP1121355B1/en
Priority to US09/807,341 priority patent/US6602882B1/en
Priority to DE69928952T priority patent/DE69928952T2/de
Priority to MA25816A priority patent/MA25009A1/fr
Priority to PE1999001028A priority patent/PE20001112A1/es
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Quinoline Compounds (AREA)
GBGB9822440.5A 1998-10-14 1998-10-14 Medicaments Ceased GB9822440D0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
GBGB9822440.5A GB9822440D0 (en) 1998-10-14 1998-10-14 Medicaments
DE69928952T DE69928952T2 (de) 1998-10-14 1999-10-11 Chinolin-derivate und ihre verwendung als antibakterielle wirkstoffe
AU63395/99A AU6339599A (en) 1998-10-14 1999-10-11 Quinoline derivatives and their use as antibacterial agents
ES99950730T ES2255306T3 (es) 1998-10-14 1999-10-11 Derivados de quinolina y su uso como agentes antibacterianos.
PCT/EP1999/007766 WO2000021952A1 (en) 1998-10-14 1999-10-11 Quinoline derivatives and their use as antibacterial agents
AT99950730T ATE312831T1 (de) 1998-10-14 1999-10-11 Chinolin-derivate und ihre verwendung als antibakterielle wirkstoffe
JP2000575858A JP2002527434A (ja) 1998-10-14 1999-10-11 キノリン誘導体および抗菌剤としてその使用
EP99950730A EP1121355B1 (en) 1998-10-14 1999-10-11 Quinoline derivatives and their use as antibacterial agents
US09/807,341 US6602882B1 (en) 1998-10-14 1999-10-11 Quinoline derivatives and their use as antibacterial agents
MA25816A MA25009A1 (fr) 1998-10-14 1999-10-12 Procede de preparation de composes derives de la piperidine pour la preparation de compositions antibacteriennes
PE1999001028A PE20001112A1 (es) 1998-10-14 1999-10-12 Derivados de quinolina como agentes antibacterianos

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9822440.5A GB9822440D0 (en) 1998-10-14 1998-10-14 Medicaments

Publications (1)

Publication Number Publication Date
GB9822440D0 true GB9822440D0 (en) 1998-12-09

Family

ID=10840577

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9822440.5A Ceased GB9822440D0 (en) 1998-10-14 1998-10-14 Medicaments

Country Status (11)

Country Link
US (1) US6602882B1 (enExample)
EP (1) EP1121355B1 (enExample)
JP (1) JP2002527434A (enExample)
AT (1) ATE312831T1 (enExample)
AU (1) AU6339599A (enExample)
DE (1) DE69928952T2 (enExample)
ES (1) ES2255306T3 (enExample)
GB (1) GB9822440D0 (enExample)
MA (1) MA25009A1 (enExample)
PE (1) PE20001112A1 (enExample)
WO (1) WO2000021952A1 (enExample)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK286420B6 (sk) 1997-09-15 2008-09-05 The Procter & Gamble Company Zlúčenina so štruktúrou chinolónu, farmaceutický prostriedok s jej obsahom a jej použitie
GB9822450D0 (en) * 1998-10-14 1998-12-09 Smithkline Beecham Plc Medicaments
GB9914486D0 (en) * 1999-06-21 1999-08-18 Smithkline Beecham Plc Medicaments
GB9917408D0 (en) 1999-07-23 1999-09-22 Smithkline Beecham Plc Compounds
GB9917406D0 (en) 1999-07-23 1999-09-22 Smithkline Beecham Plc Compounds
SE9902987D0 (sv) 1999-08-24 1999-08-24 Astra Pharma Prod Novel compounds
US6803369B1 (en) 2000-07-25 2004-10-12 Smithkline Beecham Corporation Compounds and methods for the treatment of neoplastic disease
JP2004504397A (ja) * 2000-07-26 2004-02-12 スミスクライン　ビーチャム　パブリック　リミテッド　カンパニー 抗菌活性を有するアミノピペリジンキノリン類およびそれらのアザイソステリックアナログ類
EP1320529B1 (en) * 2000-09-21 2006-05-24 Smithkline Beecham Plc Quinoline derivatives as antibacterials
GB0031088D0 (en) * 2000-12-20 2001-01-31 Smithkline Beecham Plc Medicaments
GB0031086D0 (en) * 2000-12-20 2001-01-31 Smithkline Beecham Plc Medicaments
GB0101577D0 (en) * 2001-01-22 2001-03-07 Smithkline Beecham Plc Compounds
GB0104050D0 (en) 2001-02-19 2001-04-04 Astrazeneca Ab Chemical compounds
GB0107228D0 (en) 2001-03-22 2001-05-16 Astrazeneca Ab Chemical compounds
GB0112834D0 (en) * 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
GB0112836D0 (en) * 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
GB0118238D0 (en) * 2001-07-26 2001-09-19 Smithkline Beecham Plc Medicaments
AU2002356868A1 (en) * 2001-10-30 2003-05-12 Institut National De La Recherche Scientifique Methods for the prevention or treatment of bacterial and fungal infections
SE0103818D0 (sv) 2001-11-15 2001-11-15 Astrazeneca Ab Chemical compounds
WO2003064431A2 (en) * 2002-01-29 2003-08-07 Glaxo Group Limited Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them
JP4445753B2 (ja) 2002-01-29 2010-04-07 グラクソ グループ リミテッド アミノピペリジン誘導体
TW200406413A (en) * 2002-06-26 2004-05-01 Glaxo Group Ltd Compounds
AR040336A1 (es) 2002-06-26 2005-03-30 Glaxo Group Ltd Compuesto de piperidina, uso del mismo para la fabricacion de un medicamento, composicion farmaceutica que lo comprende y procedimiento para preparar dicho compuesto
US6900224B2 (en) 2002-07-31 2005-05-31 The Procter & Gamble Company Antimicrobial quinolones, their compositions and uses
EP1560488B1 (en) 2002-11-05 2010-09-01 Glaxo Group Limited Antibacterial agents
ES2340484T3 (es) * 2002-11-05 2010-06-04 Glaxo Group Limited Agentes antibacterianos.
WO2004050036A2 (en) * 2002-12-04 2004-06-17 Glaxo Group Limited Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents
AR042486A1 (es) * 2002-12-18 2005-06-22 Glaxo Group Ltd Compuesto de quinolina y naftiridina halosustituido en la posicion 3, procedimiento para preparar el compuesto, composicion farmaceutica que lo comprende y su uso para preparar dicha composicion .
ATE440835T1 (de) * 2003-03-06 2009-09-15 Glaxo Group Ltd Heterozyklische harnstoff-derivate für die behandlung von schmerzen.
WO2004078744A2 (en) * 2003-03-07 2004-09-16 Glaxo Group Limited Urea derivatives and their use as vanilloid receptor antagonists in the treatment of pain
GB0305426D0 (en) * 2003-03-08 2003-04-16 Glaxo Group Ltd Novel compounds
SE0301369D0 (sv) 2003-05-09 2003-05-09 Astrazeneca Ab Chemical compounds
FR2867472B1 (fr) * 2004-03-12 2008-07-18 Aventis Pharma Sa Derives de quinoleines-4-substituees, leurs procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent
JP2008505920A (ja) * 2004-07-08 2008-02-28 グラクソ　グループ　リミテッド 抗菌剤
WO2006081264A1 (en) 2005-01-25 2006-08-03 Glaxo Group Limited Antibacterial agents
JP2008528586A (ja) 2005-01-25 2008-07-31 グラクソ グループ リミテッド 抗菌剤
WO2006081179A1 (en) * 2005-01-25 2006-08-03 Glaxo Group Limited Antibacterial agents
US7592334B2 (en) 2005-01-25 2009-09-22 Glaxo Group Limited Antibacterial agents
WO2006081289A2 (en) 2005-01-25 2006-08-03 Glaxo Group Limited Antibacterial agents
EP1863483A4 (en) 2005-03-31 2010-03-31 Janssen Pharmaceutica Nv Bicyclic pyrazole compounds as anti-bacteriostatic agents
MY150958A (en) 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
WO2007086016A1 (en) 2006-01-26 2007-08-02 Actelion Pharmaceuticals Ltd Tetrahydropyrane antibiotics
PT2001862E (pt) 2006-03-28 2011-07-20 Warner Chilcott Co Llc Sais de malato e polimorfos do ácido (3s,5s)-7-[3- amino-5-metil-piperidinil]-1-ciclopropil-1,4-dihidro- 8-metoxi-4-oxo-3-quinolinocarboxílico
EP1999125A2 (en) 2006-03-28 2008-12-10 The Procter and Gamble Company A coupling process for preparing quinolone intermediates
CA2685888A1 (en) * 2007-05-09 2008-11-20 Pfizer Inc. Substituted heterocyclic derivatives and their pharmaceutical use and compositions
EP2332939A1 (en) 2009-11-26 2011-06-15 Æterna Zentaris GmbH Novel Naphthyridine derivatives and the use thereof as kinase inhibitors
EP3927703B1 (en) 2019-02-19 2023-04-05 Univerza V Ljubljani Antibacterials based on monocyclic fragments coupled to aminopiperidine naphthyridine scaffold
CN114793434A (zh) 2019-10-18 2022-07-26 加利福尼亚大学董事会 作为用于治疗病原性血管病症的药剂的3-苯基磺酰基-喹啉衍生物

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4418299Y1 (enExample) 1965-01-16 1969-08-07
US4472404A (en) * 1982-08-16 1984-09-18 The Dow Chemical Company 8-Quinolinyl carbamates and their use as urinary tract antimicrobials
EP0387510A1 (de) 1989-02-10 1990-09-19 Bayer Ag Substituierte 8-Carbamoyloxychinolin-Derivate, Verfahren zu deren Herstellung, sowie deren Verwendung zur Bekämpfung von Schädlingen
JPH0495071A (ja) * 1990-08-10 1992-03-27 Kyorin Pharmaceut Co Ltd カルバミン酸誘導体
JP3169188B2 (ja) * 1991-01-31 2001-05-21 杏林製薬株式会社 カルバミン酸誘導体及びその製造方法
WO1994014801A1 (en) 1992-12-29 1994-07-07 Smithkline Beecham Plc Heterocyclic urea derivatives as 5ht2c and 5ht2b antagonists
DE69637717D1 (de) * 1995-02-02 2008-11-27 Daiichi Sankyo Co Ltd Pyridonkarbonsaüre Derivate und deren Verwendung als antibakterielle Wirkstoffe
EP0876345B1 (en) 1995-10-16 2004-08-18 Fujisawa Pharmaceutical Co., Ltd. Heterocyclic compounds as h+-atpases
JP3933244B2 (ja) 1997-04-04 2007-06-20 株式会社資生堂 アルキレンジアミン誘導体及び抗潰瘍剤、抗菌剤
DE69908555T2 (de) * 1998-01-26 2004-05-06 Smithkline Beecham P.L.C., Brentford Chinolinderivate als antibakterielles arzneimittel
FR2798656B1 (fr) 1999-09-17 2004-12-17 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, leur preparation et les compositions qui les contiennent

Also Published As

Publication number Publication date
JP2002527434A (ja) 2002-08-27
ATE312831T1 (de) 2005-12-15
DE69928952T2 (de) 2007-01-11
ES2255306T3 (es) 2006-06-16
AU6339599A (en) 2000-05-01
MA25009A1 (fr) 2000-07-01
EP1121355B1 (en) 2005-12-14
PE20001112A1 (es) 2000-10-14
DE69928952D1 (de) 2006-01-19
EP1121355A1 (en) 2001-08-08
WO2000021952A1 (en) 2000-04-20
US6602882B1 (en) 2003-08-05

Similar Documents

Publication Publication Date Title
GB9822440D0 (en) Medicaments
GB9917406D0 (en) Compounds
GB0118238D0 (en) Medicaments
GB0112836D0 (en) Medicaments
GB9822450D0 (en) Medicaments
GB0031088D0 (en) Medicaments
GB0101577D0 (en) Compounds
MXPA03000708A (es) Aminopiperidin quinolinas y sus analogos azaisostericos con actividad antibacteriana.
AU5986200A (en) Compounds
AU2002218192A1 (en) Quinoline derivatives as antibacterials
GB0217294D0 (en) Medicaments
NO954996L (no) Anvendelse av nona- og dekapeptider for fremstilling av et legemiddel for behandling av AIDS
GB0031086D0 (en) Medicaments
AU2003291227A1 (en) Antibacterial agents
EP1560821B8 (en) Antibacterial agents
NZ510153A (en) Tan-1057 derivatives with reduced toxicity and their use in medicaments for treating bacterial infections in humans and mammals
TR200100043T2 (tr) Ağrı tedavisinde ilaç hazırlanmasında tetra hidropiridin(veya 4-Hidroksipipeidin)-butilozollerin türevleri
ECSP993176A (es) Nuevos compuestos y composiciones antibacterianas

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)